SOHM Introduces Second Innovative Skincare Line Product, Salic-2(R) Gel for Acne
November 07 2013 - 9:25AM
Marketwired
SOHM Introduces Second Innovative Skincare Line Product, Salic-2(R)
Gel for Acne
New Acne Treatment Comes on the Heels of Recent and Successful
Launch of Flagship Skincare Product, FOHM by SOHM
BUENA PARK, CA--(Marketwired - Nov 7, 2013) - SOHM, Inc.
(PINKSHEETS: SHMN), a generic pharmaceutical, nutraceutical and
cosmeceutical manufacturing company, today announces the launch of
its innovative Salic-2® Gel for acne treatment. This product is
also being manufactured as private label by SOHM for Ranbaxy
Laboratories Ltd., one of the world's leading pharmaceutical
companies and part of Daiichi Sankyo Pharmaceuticals in Japan.
Shailesh Shah, president and CEO of SOHM, stated, "Salic-2® Gel
is one of the most innovative products developed by SOHM's
dermatology division for the treatment of acne. The product not
only ensures that normal acidic mantle is kept consistent but also
protects the tender skin from bacteria. We are excited to launch
this product following our successful first quarter launch of our
salicylic acid face wash, fohm by sohm at the 2013 Oscars after
party, held in Hollywood."
Sohm views the facial care product segment as an important
segment in the world's skin care industry, which is forecasted to
grow by more than 21 percent from 2010-2015 to generate almost $95
billion and reach a volume in excess of 13 billion units. Facial
care represents the leading market segment, with more than 64
percent of overall value.
The company anticipates that Salic-2® Gel will be a competitive
player in the growing skin care industry.
"SOHM team is confident that Salic-2® Gel is going to be a tough
industry competitor to similar product categories available in the
U.S. market," stated Shah. "The introduction of this second skin
care line is consistent with our goal of capturing a significant
share of the huge U.S. market through our innovative and expanding
cosmeceutical product pipeline."
ABOUT SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that
produces and markets generic drugs covering all major treatment
categories. Besides generic drugs, SOHM also has manufacturing
facilities for food supplements and cosmetics. The Company has
global headquarters located in California, U.S., with manufacturing
facilities in India. SOHM exports generic pharmaceuticals
worldwide, placing a heavy focus on distribution in emerging
markets in Africa, Latin America, and Southeast Asia. For more
information visit the company's website at: www.sohm.com
SAFE HARBOR STATEMENT
This press release contains statements, which may constitute
"forward-looking statements" within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Those
statements include statements regarding the intent, belief or
current expectations of SOHM, Inc., and members of their management
as well as the assumptions on which such statements are based.
Prospective investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve
risks and uncertainties, and that actual results may differ
materially from those contemplated by such forward-looking
statements. Important factors currently known to management that
could cause actual results to differ materially from those in
forward-statements include fluctuation of operating results, the
ability to compete successfully and the ability to complete
before-mentioned transactions. The company undertakes no obligation
to update or revise forward-looking statements to reflect changed
assumptions, the statements to reflect changed assumptions, the
occurrence of unanticipated events or changes to future operating
results.
For More Information Contact Investor Relations At SOHM Inc
714-522-6700
SOHM (PK) (USOTC:SHMN)
Historical Stock Chart
From Oct 2024 to Nov 2024
SOHM (PK) (USOTC:SHMN)
Historical Stock Chart
From Nov 2023 to Nov 2024